ANL 23.80 Increased By ▲ 0.04 (0.17%)
ASC 16.40 Increased By ▲ 0.20 (1.23%)
ASL 22.65 Increased By ▲ 0.30 (1.34%)
BOP 8.38 Increased By ▲ 0.16 (1.95%)
BYCO 8.81 Decreased By ▼ -0.12 (-1.34%)
FCCL 18.47 Decreased By ▼ -0.04 (-0.22%)
FFBL 24.60 Decreased By ▼ -0.30 (-1.2%)
FFL 18.05 Increased By ▲ 0.12 (0.67%)
FNEL 8.54 Increased By ▲ 0.06 (0.71%)
GGGL 22.30 No Change ▼ 0.00 (0%)
GGL 43.95 Increased By ▲ 0.45 (1.03%)
HUMNL 7.17 Increased By ▲ 0.32 (4.67%)
JSCL 21.58 Increased By ▲ 1.44 (7.15%)
KAPCO 38.10 Increased By ▲ 0.08 (0.21%)
KEL 3.60 Increased By ▲ 0.03 (0.84%)
MDTL 3.07 No Change ▼ 0.00 (0%)
MLCF 36.48 Decreased By ▼ -0.62 (-1.67%)
NETSOL 157.75 Increased By ▲ 3.60 (2.34%)
PACE 6.01 Decreased By ▼ -0.13 (-2.12%)
PAEL 31.65 Increased By ▲ 0.25 (0.8%)
PIBTL 9.47 Increased By ▲ 0.09 (0.96%)
POWER 8.04 Decreased By ▼ -0.01 (-0.12%)
PRL 20.98 Decreased By ▼ -0.17 (-0.8%)
PTC 10.38 Decreased By ▼ -0.22 (-2.08%)
SILK 1.69 Increased By ▲ 0.15 (9.74%)
SNGP 43.75 Increased By ▲ 0.40 (0.92%)
TELE 22.70 Decreased By ▼ -0.53 (-2.28%)
TRG 175.91 Increased By ▲ 8.66 (5.18%)
UNITY 36.97 Increased By ▲ 2.25 (6.48%)
WTL 3.33 Increased By ▲ 0.21 (6.73%)
BR100 5,026 Increased By ▲ 52.36 (1.05%)
BR30 24,773 Increased By ▲ 557.21 (2.3%)
KSE100 46,920 Increased By ▲ 203.74 (0.44%)
KSE30 18,658 Increased By ▲ 98.44 (0.53%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,004
6624hr
Pakistan Cases
1,215,821
3,01224hr
5.3% positivity
Sindh
447,678
Punjab
418,196
Balochistan
32,671
Islamabad
103,549
KPK
169,972

GENEVA: The AstraZeneca-Oxford Covid-19 vaccine can be used for people aged over 65, and also where coronavirus variants of concern are circulating, WHO experts said Wednesday, soothing fears about the jab.

The World Health Organization’s 15-member Strategic Advisory Group of Experts on Immunization (SAGE) issued interim recommendations for when and how to use the two-shot vaccine, which has yet to receive WHO emergency use authorisation.

The announcement came after the vaccine suffered several setbacks, raising questions about whether it was appropriate to use it on older people, or in places where a variant of the virus first found in South Africa is circulating.

SAGE chief Alejandro Cravioto acknowledged the lack of data on the vaccine’s efficacy for people aged over 65, which has prompted a number of countries to withhold recommending its use in older people — who are by far the most vulnerable to the virus.

But, he told journalists, “we feel that the response of this group cannot be any different from groups of a younger age”.

SAGE, he said, recommends “for the vaccine to be used for 18 years and above without an upper age limit”.

He said the experts were eagerly awaiting more specific data on the efficacy of the vaccine in people over 65, but said it “would not be appropriate” to wait with its recommendations.

“We have thousands of people dying,” he stressed.

Comments

Comments are closed.